To listen to the podcast associated with this article, please select one of the following:
iTunes, Google Play, or direct download. OBJECTIVE. This review provides historical and …

Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and
survival in patients with breast cancer, and accurate assessment of axillary LN involvement …

Methods of axillary evaluation in invasive breast cancer continue to evolve. The recent
American College of Surgeons Oncology Group Z0011 Trial is a prospective, randomized …

Background Clinical evaluation of the axilla is an area of controversy in current breast
cancer research and management. Evidence of axillary metastasis on biopsy affects all …

Sentinel lymph node (SLN) biopsy has become standard care for management of the axilla
in invasive breast cancer, replacing axillary lymph node dissection (ALND) in most subjects …

Axillary management in patients with breast cancer has become much less invasive with the
introduction of sentinel lymph node biopsy (SLNB). However, over 70% of SLNBs are …

Background Management of the axilla in breast cancer patients has evolved from routine
axillary lymph node dissection (ALND) for all patients to a highly selective approach based …

Background. Breast cancer treatment has rapidly changed in the last few years. Particularly,
treatment of patients with axillary nodal involvement has evolved after publication of several …

Over the past decade, axillary management in breast cancer has fundamentally shifted. The
former notion that any degree of axillary nodal involvement warrants axillary lymph node …

Sentinel lymph node (SLN) biopsy is now used worldwide. It has led to many changes in
how we manage the axilla in patients with breast cancer. This review covers four areas of …